Cite
HARVARD Citation
Michelsen, B. et al. (2020). Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration. RMD open. 6 (3), p. . [Online].